oddb2xml 3.0.2 → 3.0.3
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
- checksums.yaml +4 -4
- data/CLAUDE.md +1 -1
- data/Gemfile.lock +1 -1
- data/History.txt +8 -0
- data/README.md +3 -5
- data/lib/oddb2xml/cli.rb +8 -3
- data/lib/oddb2xml/downloader.rb +2 -7
- data/lib/oddb2xml/extractor.rb +3 -1
- data/lib/oddb2xml/fhir_support.rb +86 -26
- data/lib/oddb2xml/options.rb +2 -2
- data/lib/oddb2xml/version.rb +1 -1
- data/spec/builder_spec.rb +1 -1
- data/spec/data/Refdata.Articles.xml +853 -0
- data/spec/downloader_spec.rb +4 -4
- data/spec/extractor_spec.rb +3 -3
- data/spec/fixtures/vcr_cassettes/oddb2xml.json +2092 -1980
- data/spec/options_spec.rb +2 -0
- data/spec/spec_helper.rb +5 -3
- metadata +4 -2
|
@@ -0,0 +1,853 @@
|
|
|
1
|
+
<?xml version="1.0" encoding="utf-8"?>
|
|
2
|
+
<Articles xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://simisinfo.refdata.ch/Articles/1.0/" totalArticles="30" generatedOn="2026-03-09T01:00:07Z">
|
|
3
|
+
<Article>
|
|
4
|
+
<MedicinalProduct>
|
|
5
|
+
<Identifier>CH-7601001000674-00585</Identifier>
|
|
6
|
+
<Domain>Human</Domain>
|
|
7
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
8
|
+
<RegulatedAuthorisationIdentifier>0058501</RegulatedAuthorisationIdentifier>
|
|
9
|
+
<ProductClassification>
|
|
10
|
+
<ProductClass>PHARMA</ProductClass>
|
|
11
|
+
<Atc>J07BK01</Atc>
|
|
12
|
+
</ProductClassification>
|
|
13
|
+
</MedicinalProduct>
|
|
14
|
+
<PackagedProduct>
|
|
15
|
+
<Identifier>CH-7601001000674-00585-001</Identifier>
|
|
16
|
+
<RegulatedAuthorisationIdentifier>00585001</RegulatedAuthorisationIdentifier>
|
|
17
|
+
<DataCarrierIdentifier>7680005850010</DataCarrierIdentifier>
|
|
18
|
+
<Holder>
|
|
19
|
+
<Identifier>7601001000674</Identifier>
|
|
20
|
+
<Name>GlaxoSmithKline AG</Name>
|
|
21
|
+
</Holder>
|
|
22
|
+
<Name>
|
|
23
|
+
<Language>DE</Language>
|
|
24
|
+
<FullName>VARILRIX Trockensub c Solv Fertspr 0.5 ml</FullName>
|
|
25
|
+
</Name>
|
|
26
|
+
<Name>
|
|
27
|
+
<Language>FR</Language>
|
|
28
|
+
<FullName>VARILRIX subst sèche c solv ser pré 0.5 ml</FullName>
|
|
29
|
+
</Name>
|
|
30
|
+
</PackagedProduct>
|
|
31
|
+
</Article>
|
|
32
|
+
<Article>
|
|
33
|
+
<MedicinalProduct>
|
|
34
|
+
<Identifier>CH-7601001001541-54534</Identifier>
|
|
35
|
+
<Domain>Human</Domain>
|
|
36
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
37
|
+
<RegulatedAuthorisationIdentifier>5453401</RegulatedAuthorisationIdentifier>
|
|
38
|
+
<ProductClassification>
|
|
39
|
+
<ProductClass>PHARMA</ProductClass>
|
|
40
|
+
<Atc>N06DX02</Atc>
|
|
41
|
+
</ProductClassification>
|
|
42
|
+
</MedicinalProduct>
|
|
43
|
+
<PackagedProduct>
|
|
44
|
+
<Identifier>CH-7601001001541-54534-001</Identifier>
|
|
45
|
+
<RegulatedAuthorisationIdentifier>54534001</RegulatedAuthorisationIdentifier>
|
|
46
|
+
<DataCarrierIdentifier>7680545340019</DataCarrierIdentifier>
|
|
47
|
+
<Holder>
|
|
48
|
+
<Identifier>7601001001541</Identifier>
|
|
49
|
+
<Name>Schwabe Pharma AG</Name>
|
|
50
|
+
</Holder>
|
|
51
|
+
<Name>
|
|
52
|
+
<Language>DE</Language>
|
|
53
|
+
<FullName>TEBOKAN Filmtabl 240 mg 30 Stk</FullName>
|
|
54
|
+
</Name>
|
|
55
|
+
<Name>
|
|
56
|
+
<Language>FR</Language>
|
|
57
|
+
<FullName>TEBOKAN cpr pell 240 mg 30 pce</FullName>
|
|
58
|
+
</Name>
|
|
59
|
+
</PackagedProduct>
|
|
60
|
+
</Article>
|
|
61
|
+
<Article>
|
|
62
|
+
<MedicinalProduct>
|
|
63
|
+
<Identifier>CH-7601001402539-54015</Identifier>
|
|
64
|
+
<Domain>Human</Domain>
|
|
65
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
66
|
+
<RegulatedAuthorisationIdentifier>5401501</RegulatedAuthorisationIdentifier>
|
|
67
|
+
<ProductClassification>
|
|
68
|
+
<ProductClass>PHARMA</ProductClass>
|
|
69
|
+
<Atc>N01BB09</Atc>
|
|
70
|
+
</ProductClassification>
|
|
71
|
+
</MedicinalProduct>
|
|
72
|
+
<PackagedProduct>
|
|
73
|
+
<Identifier>CH-7601001402539-54015-011</Identifier>
|
|
74
|
+
<RegulatedAuthorisationIdentifier>54015011</RegulatedAuthorisationIdentifier>
|
|
75
|
+
<DataCarrierIdentifier>7680540150118</DataCarrierIdentifier>
|
|
76
|
+
<Holder>
|
|
77
|
+
<Identifier>7601001402539</Identifier>
|
|
78
|
+
<Name>Aspen Pharma Schweiz GmbH</Name>
|
|
79
|
+
</Holder>
|
|
80
|
+
<Name>
|
|
81
|
+
<Language>DE</Language>
|
|
82
|
+
<FullName>NAROPIN Inj Lös 0.2 % 10ml Duofit Amp 5 Stk</FullName>
|
|
83
|
+
</Name>
|
|
84
|
+
<Name>
|
|
85
|
+
<Language>FR</Language>
|
|
86
|
+
<FullName>NAROPIN sol inj 0.2 % 10ml amp duofit 5 pce</FullName>
|
|
87
|
+
</Name>
|
|
88
|
+
</PackagedProduct>
|
|
89
|
+
</Article>
|
|
90
|
+
<Article>
|
|
91
|
+
<MedicinalProduct>
|
|
92
|
+
<Identifier>CH-7601001395756-56352</Identifier>
|
|
93
|
+
<Domain>Human</Domain>
|
|
94
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
95
|
+
<RegulatedAuthorisationIdentifier>5635201</RegulatedAuthorisationIdentifier>
|
|
96
|
+
<ProductClassification>
|
|
97
|
+
<ProductClass>PHARMA</ProductClass>
|
|
98
|
+
<Atc>B02BD02</Atc>
|
|
99
|
+
</ProductClassification>
|
|
100
|
+
</MedicinalProduct>
|
|
101
|
+
<PackagedProduct>
|
|
102
|
+
<Identifier>CH-7601001395756-56352-017</Identifier>
|
|
103
|
+
<RegulatedAuthorisationIdentifier>56352017</RegulatedAuthorisationIdentifier>
|
|
104
|
+
<DataCarrierIdentifier>7680563520172</DataCarrierIdentifier>
|
|
105
|
+
<Holder>
|
|
106
|
+
<Identifier>7601001395756</Identifier>
|
|
107
|
+
<Name>Shire Switzerland GmbH</Name>
|
|
108
|
+
</Holder>
|
|
109
|
+
<Name>
|
|
110
|
+
<Language>DE</Language>
|
|
111
|
+
<FullName>ADVATE Trockensub 250 IE c Solv 2 ml Durchstf</FullName>
|
|
112
|
+
</Name>
|
|
113
|
+
<Name>
|
|
114
|
+
<Language>FR</Language>
|
|
115
|
+
<FullName>ADVATE subst sèche 250 UI c solv 2 ml flac</FullName>
|
|
116
|
+
</Name>
|
|
117
|
+
</PackagedProduct>
|
|
118
|
+
</Article>
|
|
119
|
+
<Article>
|
|
120
|
+
<MedicinalProduct>
|
|
121
|
+
<Identifier>CH-7612053000000-65856</Identifier>
|
|
122
|
+
<Domain>Human</Domain>
|
|
123
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
124
|
+
<RegulatedAuthorisationIdentifier>6585601</RegulatedAuthorisationIdentifier>
|
|
125
|
+
<ProductClassification>
|
|
126
|
+
<ProductClass>PHARMA</ProductClass>
|
|
127
|
+
<Atc>A11CC05</Atc>
|
|
128
|
+
</ProductClassification>
|
|
129
|
+
</MedicinalProduct>
|
|
130
|
+
<PackagedProduct>
|
|
131
|
+
<Identifier>CH-7612053000000-65856-001</Identifier>
|
|
132
|
+
<RegulatedAuthorisationIdentifier>65856001</RegulatedAuthorisationIdentifier>
|
|
133
|
+
<DataCarrierIdentifier>7680658560014</DataCarrierIdentifier>
|
|
134
|
+
<Holder>
|
|
135
|
+
<Identifier>7612053000000</Identifier>
|
|
136
|
+
<Name>Gebro Pharma AG</Name>
|
|
137
|
+
</Holder>
|
|
138
|
+
<Name>
|
|
139
|
+
<Language>DE</Language>
|
|
140
|
+
<FullName>DIBASE Tropfen 10000 IE/ml Fl 10 ml</FullName>
|
|
141
|
+
</Name>
|
|
142
|
+
<Name>
|
|
143
|
+
<Language>FR</Language>
|
|
144
|
+
<FullName>DIBASE gouttes 10000 UI/ml fl 10 ml</FullName>
|
|
145
|
+
</Name>
|
|
146
|
+
</PackagedProduct>
|
|
147
|
+
</Article>
|
|
148
|
+
<Article>
|
|
149
|
+
<MedicinalProduct>
|
|
150
|
+
<Identifier>CH-7601001402218-55558</Identifier>
|
|
151
|
+
<Domain>Human</Domain>
|
|
152
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
153
|
+
<RegulatedAuthorisationIdentifier>5555801</RegulatedAuthorisationIdentifier>
|
|
154
|
+
<ProductClassification>
|
|
155
|
+
<ProductClass>PHARMA</ProductClass>
|
|
156
|
+
<Atc>J01XX08</Atc>
|
|
157
|
+
</ProductClassification>
|
|
158
|
+
</MedicinalProduct>
|
|
159
|
+
<PackagedProduct>
|
|
160
|
+
<Identifier>CH-7601001402218-55558-005</Identifier>
|
|
161
|
+
<RegulatedAuthorisationIdentifier>55558005</RegulatedAuthorisationIdentifier>
|
|
162
|
+
<DataCarrierIdentifier>7680555580054</DataCarrierIdentifier>
|
|
163
|
+
<Holder>
|
|
164
|
+
<Identifier>7601001402218</Identifier>
|
|
165
|
+
<Name>Pfizer PFE Switzerland GmbH</Name>
|
|
166
|
+
</Holder>
|
|
167
|
+
<Name>
|
|
168
|
+
<Language>DE</Language>
|
|
169
|
+
<FullName>ZYVOXID Filmtabl 600 mg 10 Stk</FullName>
|
|
170
|
+
</Name>
|
|
171
|
+
<Name>
|
|
172
|
+
<Language>FR</Language>
|
|
173
|
+
<FullName>ZYVOXID cpr pell 600 mg 10 pce</FullName>
|
|
174
|
+
</Name>
|
|
175
|
+
</PackagedProduct>
|
|
176
|
+
</Article>
|
|
177
|
+
<Article>
|
|
178
|
+
<MedicinalProduct>
|
|
179
|
+
<Identifier>CH-7601001320451-62069</Identifier>
|
|
180
|
+
<Domain>Human</Domain>
|
|
181
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
182
|
+
<RegulatedAuthorisationIdentifier>6206901</RegulatedAuthorisationIdentifier>
|
|
183
|
+
<ProductClassification>
|
|
184
|
+
<ProductClass>PHARMA</ProductClass>
|
|
185
|
+
<Atc>N03AX14</Atc>
|
|
186
|
+
</ProductClassification>
|
|
187
|
+
</MedicinalProduct>
|
|
188
|
+
<PackagedProduct>
|
|
189
|
+
<Identifier>CH-7601001320451-62069-008</Identifier>
|
|
190
|
+
<RegulatedAuthorisationIdentifier>62069008</RegulatedAuthorisationIdentifier>
|
|
191
|
+
<DataCarrierIdentifier>7680620690084</DataCarrierIdentifier>
|
|
192
|
+
<Holder>
|
|
193
|
+
<Identifier>7601001320451</Identifier>
|
|
194
|
+
<Name>Desitin Pharma GmbH</Name>
|
|
195
|
+
</Holder>
|
|
196
|
+
<Name>
|
|
197
|
+
<Language>DE</Language>
|
|
198
|
+
<FullName>LEVETIRACETAM DESITIN Mini Filmtab 250 mg 30 Stk</FullName>
|
|
199
|
+
</Name>
|
|
200
|
+
<Name>
|
|
201
|
+
<Language>FR</Language>
|
|
202
|
+
<FullName>LEVETIRACETAM DESITIN mini cpr pel 250 mg 30 pce</FullName>
|
|
203
|
+
</Name>
|
|
204
|
+
</PackagedProduct>
|
|
205
|
+
</Article>
|
|
206
|
+
<Article>
|
|
207
|
+
<MedicinalProduct>
|
|
208
|
+
<Identifier>CH-7601001374539-35366</Identifier>
|
|
209
|
+
<Domain>Human</Domain>
|
|
210
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
211
|
+
<RegulatedAuthorisationIdentifier>3536601</RegulatedAuthorisationIdentifier>
|
|
212
|
+
<ProductClassification>
|
|
213
|
+
<ProductClass>PHARMA</ProductClass>
|
|
214
|
+
<Atc>B03AE10</Atc>
|
|
215
|
+
</ProductClassification>
|
|
216
|
+
</MedicinalProduct>
|
|
217
|
+
<PackagedProduct>
|
|
218
|
+
<Identifier>CH-7601001374539-35366-016</Identifier>
|
|
219
|
+
<RegulatedAuthorisationIdentifier>35366016</RegulatedAuthorisationIdentifier>
|
|
220
|
+
<DataCarrierIdentifier>7680353660163</DataCarrierIdentifier>
|
|
221
|
+
<Holder>
|
|
222
|
+
<Identifier>7601001374539</Identifier>
|
|
223
|
+
<Name>Farmaceutica Teofarma Suisse SA</Name>
|
|
224
|
+
</Holder>
|
|
225
|
+
<Name>
|
|
226
|
+
<Language>DE</Language>
|
|
227
|
+
<FullName>KENDURAL Depottabl 30 Stk</FullName>
|
|
228
|
+
</Name>
|
|
229
|
+
<Name>
|
|
230
|
+
<Language>FR</Language>
|
|
231
|
+
<FullName>KENDURAL cpr dépôt 30 pce</FullName>
|
|
232
|
+
</Name>
|
|
233
|
+
</PackagedProduct>
|
|
234
|
+
</Article>
|
|
235
|
+
<Article>
|
|
236
|
+
<MedicinalProduct>
|
|
237
|
+
<Identifier>CH-7601001392175-53662</Identifier>
|
|
238
|
+
<Domain>Human</Domain>
|
|
239
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
240
|
+
<RegulatedAuthorisationIdentifier>5366201</RegulatedAuthorisationIdentifier>
|
|
241
|
+
<ProductClassification>
|
|
242
|
+
<ProductClass>PHARMA</ProductClass>
|
|
243
|
+
<Atc>J05AF05</Atc>
|
|
244
|
+
</ProductClassification>
|
|
245
|
+
</MedicinalProduct>
|
|
246
|
+
<PackagedProduct>
|
|
247
|
+
<Identifier>CH-7601001392175-53662-013</Identifier>
|
|
248
|
+
<RegulatedAuthorisationIdentifier>53662013</RegulatedAuthorisationIdentifier>
|
|
249
|
+
<DataCarrierIdentifier>7680536620137</DataCarrierIdentifier>
|
|
250
|
+
<Holder>
|
|
251
|
+
<Identifier>7601001392175</Identifier>
|
|
252
|
+
<Name>ViiV Healthcare GmbH</Name>
|
|
253
|
+
</Holder>
|
|
254
|
+
<Name>
|
|
255
|
+
<Language>DE</Language>
|
|
256
|
+
<FullName>3TC Filmtabl 150 mg 60 Stk</FullName>
|
|
257
|
+
</Name>
|
|
258
|
+
<Name>
|
|
259
|
+
<Language>FR</Language>
|
|
260
|
+
<FullName>3TC cpr pell 150 mg 60 pce</FullName>
|
|
261
|
+
</Name>
|
|
262
|
+
</PackagedProduct>
|
|
263
|
+
</Article>
|
|
264
|
+
<Article>
|
|
265
|
+
<MedicinalProduct>
|
|
266
|
+
<Identifier>CH-7601001002258-16105</Identifier>
|
|
267
|
+
<Domain>Human</Domain>
|
|
268
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
269
|
+
<RegulatedAuthorisationIdentifier>1610501</RegulatedAuthorisationIdentifier>
|
|
270
|
+
<ProductClassification>
|
|
271
|
+
<ProductClass>PHARMA</ProductClass>
|
|
272
|
+
<Atc>C05BA01</Atc>
|
|
273
|
+
</ProductClassification>
|
|
274
|
+
</MedicinalProduct>
|
|
275
|
+
<PackagedProduct>
|
|
276
|
+
<Identifier>CH-7601001002258-16105-058</Identifier>
|
|
277
|
+
<RegulatedAuthorisationIdentifier>16105058</RegulatedAuthorisationIdentifier>
|
|
278
|
+
<DataCarrierIdentifier>7680161050583</DataCarrierIdentifier>
|
|
279
|
+
<Holder>
|
|
280
|
+
<Identifier>7601001002258</Identifier>
|
|
281
|
+
<Name>Medinova AG</Name>
|
|
282
|
+
</Holder>
|
|
283
|
+
<Name>
|
|
284
|
+
<Language>DE</Language>
|
|
285
|
+
<FullName>HIRUDOID Creme 3 mg/g 40 g</FullName>
|
|
286
|
+
</Name>
|
|
287
|
+
<Name>
|
|
288
|
+
<Language>FR</Language>
|
|
289
|
+
<FullName>HIRUDOID crème 3 mg/g 40 g</FullName>
|
|
290
|
+
</Name>
|
|
291
|
+
</PackagedProduct>
|
|
292
|
+
</Article>
|
|
293
|
+
<Article>
|
|
294
|
+
<MedicinalProduct>
|
|
295
|
+
<Identifier>CH-7601001002012-32475</Identifier>
|
|
296
|
+
<Domain>Human</Domain>
|
|
297
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
298
|
+
<RegulatedAuthorisationIdentifier>3247501</RegulatedAuthorisationIdentifier>
|
|
299
|
+
<ProductClassification>
|
|
300
|
+
<ProductClass>PHARMA</ProductClass>
|
|
301
|
+
<Atc>A06AA01</Atc>
|
|
302
|
+
</ProductClassification>
|
|
303
|
+
</MedicinalProduct>
|
|
304
|
+
<PackagedProduct>
|
|
305
|
+
<Identifier>CH-7601001002012-32475-019</Identifier>
|
|
306
|
+
<RegulatedAuthorisationIdentifier>32475019</RegulatedAuthorisationIdentifier>
|
|
307
|
+
<DataCarrierIdentifier>7680324750190</DataCarrierIdentifier>
|
|
308
|
+
<Holder>
|
|
309
|
+
<Identifier>7601001002012</Identifier>
|
|
310
|
+
<Name>Actipharm SA</Name>
|
|
311
|
+
</Holder>
|
|
312
|
+
<Name>
|
|
313
|
+
<Language>DE</Language>
|
|
314
|
+
<FullName>LANSOYL Gel 225 g</FullName>
|
|
315
|
+
</Name>
|
|
316
|
+
<Name>
|
|
317
|
+
<Language>FR</Language>
|
|
318
|
+
<FullName>LANSOYL gel 225 g</FullName>
|
|
319
|
+
</Name>
|
|
320
|
+
</PackagedProduct>
|
|
321
|
+
</Article>
|
|
322
|
+
<Article>
|
|
323
|
+
<MedicinalProduct>
|
|
324
|
+
<Identifier>CH-7601001001121-57323</Identifier>
|
|
325
|
+
<Domain>Human</Domain>
|
|
326
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
327
|
+
<RegulatedAuthorisationIdentifier>5732301</RegulatedAuthorisationIdentifier>
|
|
328
|
+
<ProductClassification>
|
|
329
|
+
<ProductClass>PHARMA</ProductClass>
|
|
330
|
+
<Atc>A02BC03</Atc>
|
|
331
|
+
</ProductClassification>
|
|
332
|
+
</MedicinalProduct>
|
|
333
|
+
<PackagedProduct>
|
|
334
|
+
<Identifier>CH-7601001001121-57323-001</Identifier>
|
|
335
|
+
<RegulatedAuthorisationIdentifier>57323001</RegulatedAuthorisationIdentifier>
|
|
336
|
+
<DataCarrierIdentifier>7680573230016</DataCarrierIdentifier>
|
|
337
|
+
<Holder>
|
|
338
|
+
<Identifier>7601001001121</Identifier>
|
|
339
|
+
<Name>Mepha Pharma AG</Name>
|
|
340
|
+
</Holder>
|
|
341
|
+
<Name>
|
|
342
|
+
<Language>DE</Language>
|
|
343
|
+
<FullName>LANSOPRAZOL Mepha Kaps 15 mg Fl 60 Stk</FullName>
|
|
344
|
+
</Name>
|
|
345
|
+
<Name>
|
|
346
|
+
<Language>FR</Language>
|
|
347
|
+
<FullName>LANSOPRAZOL Mepha caps 15 mg fl 60 pce</FullName>
|
|
348
|
+
</Name>
|
|
349
|
+
</PackagedProduct>
|
|
350
|
+
</Article>
|
|
351
|
+
<Article>
|
|
352
|
+
<MedicinalProduct>
|
|
353
|
+
<Identifier>CH-7601001261853-53290</Identifier>
|
|
354
|
+
<Domain>Human</Domain>
|
|
355
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
356
|
+
<RegulatedAuthorisationIdentifier>5329001</RegulatedAuthorisationIdentifier>
|
|
357
|
+
<ProductClassification>
|
|
358
|
+
<ProductClass>PHARMA</ProductClass>
|
|
359
|
+
<Atc>A10AB04</Atc>
|
|
360
|
+
</ProductClassification>
|
|
361
|
+
</MedicinalProduct>
|
|
362
|
+
<PackagedProduct>
|
|
363
|
+
<Identifier>CH-7601001261853-53290-019</Identifier>
|
|
364
|
+
<RegulatedAuthorisationIdentifier>53290019</RegulatedAuthorisationIdentifier>
|
|
365
|
+
<DataCarrierIdentifier>7680532900196</DataCarrierIdentifier>
|
|
366
|
+
<Holder>
|
|
367
|
+
<Identifier>7601001261853</Identifier>
|
|
368
|
+
<Name>Eli Lilly (Suisse) SA</Name>
|
|
369
|
+
</Holder>
|
|
370
|
+
<Name>
|
|
371
|
+
<Language>DE</Language>
|
|
372
|
+
<FullName>HUMALOG Inj Lös 100 IE/ml Durchstf 10 ml</FullName>
|
|
373
|
+
</Name>
|
|
374
|
+
<Name>
|
|
375
|
+
<Language>FR</Language>
|
|
376
|
+
<FullName>HUMALOG sol inj 100 UI/ml flac 10 ml</FullName>
|
|
377
|
+
</Name>
|
|
378
|
+
</PackagedProduct>
|
|
379
|
+
</Article>
|
|
380
|
+
<Article>
|
|
381
|
+
<MedicinalProduct>
|
|
382
|
+
<Identifier>CH-7640128710004-00277</Identifier>
|
|
383
|
+
<Domain>Human</Domain>
|
|
384
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
385
|
+
<RegulatedAuthorisationIdentifier>0027701</RegulatedAuthorisationIdentifier>
|
|
386
|
+
<ProductClassification>
|
|
387
|
+
<ProductClass>PHARMA</ProductClass>
|
|
388
|
+
<Atc>J06AA99</Atc>
|
|
389
|
+
</ProductClassification>
|
|
390
|
+
</MedicinalProduct>
|
|
391
|
+
<PackagedProduct>
|
|
392
|
+
<Identifier>CH-7640128710004-00277-001</Identifier>
|
|
393
|
+
<RegulatedAuthorisationIdentifier>00277001</RegulatedAuthorisationIdentifier>
|
|
394
|
+
<DataCarrierIdentifier>7680002770014</DataCarrierIdentifier>
|
|
395
|
+
<Holder>
|
|
396
|
+
<Identifier>7640128710004</Identifier>
|
|
397
|
+
<Name>Serolab SA (succursale de Remaufens)</Name>
|
|
398
|
+
</Holder>
|
|
399
|
+
<Name>
|
|
400
|
+
<Language>DE</Language>
|
|
401
|
+
<FullName>SEROCYTOL Herz-Gefässe Supp 3 Stk</FullName>
|
|
402
|
+
</Name>
|
|
403
|
+
<Name>
|
|
404
|
+
<Language>FR</Language>
|
|
405
|
+
<FullName>SEROCYTOL Coeur-Vaisseaux supp 3 pce</FullName>
|
|
406
|
+
</Name>
|
|
407
|
+
</PackagedProduct>
|
|
408
|
+
</Article>
|
|
409
|
+
<Article>
|
|
410
|
+
<MedicinalProduct>
|
|
411
|
+
<Identifier>CH-7640128710004-00278</Identifier>
|
|
412
|
+
<Domain>Human</Domain>
|
|
413
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
414
|
+
<RegulatedAuthorisationIdentifier>0027801</RegulatedAuthorisationIdentifier>
|
|
415
|
+
<ProductClassification>
|
|
416
|
+
<ProductClass>PHARMA</ProductClass>
|
|
417
|
+
<Atc>J06AA99</Atc>
|
|
418
|
+
</ProductClassification>
|
|
419
|
+
</MedicinalProduct>
|
|
420
|
+
<PackagedProduct>
|
|
421
|
+
<Identifier>CH-7640128710004-00278-001</Identifier>
|
|
422
|
+
<RegulatedAuthorisationIdentifier>00278001</RegulatedAuthorisationIdentifier>
|
|
423
|
+
<DataCarrierIdentifier>7680002780013</DataCarrierIdentifier>
|
|
424
|
+
<Holder>
|
|
425
|
+
<Identifier>7640128710004</Identifier>
|
|
426
|
+
<Name>Serolab SA (succursale de Remaufens)</Name>
|
|
427
|
+
</Holder>
|
|
428
|
+
<Name>
|
|
429
|
+
<Language>DE</Language>
|
|
430
|
+
<FullName>SEROCYTOL Kolon Supp 3 Stk</FullName>
|
|
431
|
+
</Name>
|
|
432
|
+
<Name>
|
|
433
|
+
<Language>FR</Language>
|
|
434
|
+
<FullName>SEROCYTOL Côlon supp 3 pce</FullName>
|
|
435
|
+
</Name>
|
|
436
|
+
</PackagedProduct>
|
|
437
|
+
</Article>
|
|
438
|
+
<Article>
|
|
439
|
+
<MedicinalProduct>
|
|
440
|
+
<Identifier>CH-7601001000902-40662</Identifier>
|
|
441
|
+
<Domain>Human</Domain>
|
|
442
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
443
|
+
<RegulatedAuthorisationIdentifier>4066201</RegulatedAuthorisationIdentifier>
|
|
444
|
+
<ProductClassification>
|
|
445
|
+
<ProductClass>PHARMA</ProductClass>
|
|
446
|
+
<Atc>D01AC20</Atc>
|
|
447
|
+
</ProductClassification>
|
|
448
|
+
</MedicinalProduct>
|
|
449
|
+
<PackagedProduct>
|
|
450
|
+
<Identifier>CH-7601001000902-40662-014</Identifier>
|
|
451
|
+
<RegulatedAuthorisationIdentifier>40662014</RegulatedAuthorisationIdentifier>
|
|
452
|
+
<DataCarrierIdentifier>7680406620144</DataCarrierIdentifier>
|
|
453
|
+
<Holder>
|
|
454
|
+
<Identifier>7601001000902</Identifier>
|
|
455
|
+
<Name>Janssen-Cilag AG</Name>
|
|
456
|
+
</Holder>
|
|
457
|
+
<Name>
|
|
458
|
+
<Language>DE</Language>
|
|
459
|
+
<FullName>PEVISONE Creme 15 g</FullName>
|
|
460
|
+
</Name>
|
|
461
|
+
<Name>
|
|
462
|
+
<Language>FR</Language>
|
|
463
|
+
<FullName>PEVISONE crème 15 g</FullName>
|
|
464
|
+
</Name>
|
|
465
|
+
</PackagedProduct>
|
|
466
|
+
</Article>
|
|
467
|
+
<Article>
|
|
468
|
+
<MedicinalProduct>
|
|
469
|
+
<Identifier>CH-7601001000902-40662</Identifier>
|
|
470
|
+
<Domain>Human</Domain>
|
|
471
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
472
|
+
<RegulatedAuthorisationIdentifier>4066201</RegulatedAuthorisationIdentifier>
|
|
473
|
+
<ProductClassification>
|
|
474
|
+
<ProductClass>PHARMA</ProductClass>
|
|
475
|
+
<Atc>D01AC20</Atc>
|
|
476
|
+
</ProductClassification>
|
|
477
|
+
</MedicinalProduct>
|
|
478
|
+
<PackagedProduct>
|
|
479
|
+
<Identifier>CH-7601001000902-40662-022</Identifier>
|
|
480
|
+
<RegulatedAuthorisationIdentifier>40662022</RegulatedAuthorisationIdentifier>
|
|
481
|
+
<DataCarrierIdentifier>7680406620229</DataCarrierIdentifier>
|
|
482
|
+
<Holder>
|
|
483
|
+
<Identifier>7601001000902</Identifier>
|
|
484
|
+
<Name>Janssen-Cilag AG</Name>
|
|
485
|
+
</Holder>
|
|
486
|
+
<Name>
|
|
487
|
+
<Language>DE</Language>
|
|
488
|
+
<FullName>PEVISONE Creme 30 g</FullName>
|
|
489
|
+
</Name>
|
|
490
|
+
<Name>
|
|
491
|
+
<Language>FR</Language>
|
|
492
|
+
<FullName>PEVISONE crème 30 g</FullName>
|
|
493
|
+
</Name>
|
|
494
|
+
</PackagedProduct>
|
|
495
|
+
</Article>
|
|
496
|
+
<Article>
|
|
497
|
+
<MedicinalProduct>
|
|
498
|
+
<Identifier>CH-7601001379947-58734</Identifier>
|
|
499
|
+
<Domain>Human</Domain>
|
|
500
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
501
|
+
<RegulatedAuthorisationIdentifier>5873401</RegulatedAuthorisationIdentifier>
|
|
502
|
+
<ProductClassification>
|
|
503
|
+
<ProductClass>PHARMA</ProductClass>
|
|
504
|
+
<Atc>L01CX01</Atc>
|
|
505
|
+
</ProductClassification>
|
|
506
|
+
</MedicinalProduct>
|
|
507
|
+
<PackagedProduct>
|
|
508
|
+
<Identifier>CH-7601001379947-58734-001</Identifier>
|
|
509
|
+
<RegulatedAuthorisationIdentifier>58734001</RegulatedAuthorisationIdentifier>
|
|
510
|
+
<DataCarrierIdentifier>7680587340015</DataCarrierIdentifier>
|
|
511
|
+
<Holder>
|
|
512
|
+
<Identifier>7601001379947</Identifier>
|
|
513
|
+
<Name>PharmaMar AG</Name>
|
|
514
|
+
</Holder>
|
|
515
|
+
<Name>
|
|
516
|
+
<Language>DE</Language>
|
|
517
|
+
<FullName>YONDELIS Trockensub 0.25 mg Durchstf</FullName>
|
|
518
|
+
</Name>
|
|
519
|
+
<Name>
|
|
520
|
+
<Language>FR</Language>
|
|
521
|
+
<FullName>YONDELIS subst sèche 0.25 mg flac</FullName>
|
|
522
|
+
</Name>
|
|
523
|
+
</PackagedProduct>
|
|
524
|
+
</Article>
|
|
525
|
+
<Article>
|
|
526
|
+
<MedicinalProduct>
|
|
527
|
+
<Identifier>CH-7601001397033-62716</Identifier>
|
|
528
|
+
<Domain>Human</Domain>
|
|
529
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
530
|
+
<RegulatedAuthorisationIdentifier>6271601</RegulatedAuthorisationIdentifier>
|
|
531
|
+
<ProductClassification>
|
|
532
|
+
<ProductClass>PHARMA</ProductClass>
|
|
533
|
+
<Atc>R05FB02</Atc>
|
|
534
|
+
</ProductClassification>
|
|
535
|
+
</MedicinalProduct>
|
|
536
|
+
<PackagedProduct>
|
|
537
|
+
<Identifier>CH-7601001397033-62716-001</Identifier>
|
|
538
|
+
<RegulatedAuthorisationIdentifier>62716001</RegulatedAuthorisationIdentifier>
|
|
539
|
+
<DataCarrierIdentifier>7680627160016</DataCarrierIdentifier>
|
|
540
|
+
<Holder>
|
|
541
|
+
<Identifier>7601001397033</Identifier>
|
|
542
|
+
<Name>Coop Vitality Health Care GmbH</Name>
|
|
543
|
+
</Holder>
|
|
544
|
+
<Name>
|
|
545
|
+
<Language>DE</Language>
|
|
546
|
+
<FullName>COOP VITALITY Bronchialpastillen 40 Stk</FullName>
|
|
547
|
+
</Name>
|
|
548
|
+
<Name>
|
|
549
|
+
<Language>FR</Language>
|
|
550
|
+
<FullName>COOP VITALITY pastilles bronchiques 40 pce</FullName>
|
|
551
|
+
</Name>
|
|
552
|
+
</PackagedProduct>
|
|
553
|
+
</Article>
|
|
554
|
+
<Article>
|
|
555
|
+
<MedicinalProduct>
|
|
556
|
+
<Identifier>CH-7601001348622-65160</Identifier>
|
|
557
|
+
<Domain>Human</Domain>
|
|
558
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
559
|
+
<RegulatedAuthorisationIdentifier>6516001</RegulatedAuthorisationIdentifier>
|
|
560
|
+
<ProductClassification>
|
|
561
|
+
<ProductClass>PHARMA</ProductClass>
|
|
562
|
+
<Atc>L01XX46</Atc>
|
|
563
|
+
</ProductClassification>
|
|
564
|
+
</MedicinalProduct>
|
|
565
|
+
<PackagedProduct>
|
|
566
|
+
<Identifier>CH-7601001348622-65160-001</Identifier>
|
|
567
|
+
<RegulatedAuthorisationIdentifier>65160001</RegulatedAuthorisationIdentifier>
|
|
568
|
+
<DataCarrierIdentifier>7680651600014</DataCarrierIdentifier>
|
|
569
|
+
<Holder>
|
|
570
|
+
<Identifier>7601001348622</Identifier>
|
|
571
|
+
<Name>AstraZeneca AG</Name>
|
|
572
|
+
</Holder>
|
|
573
|
+
<Name>
|
|
574
|
+
<Language>DE</Language>
|
|
575
|
+
<FullName>LYNPARZA Kaps 50 mg 448 Stk</FullName>
|
|
576
|
+
</Name>
|
|
577
|
+
<Name>
|
|
578
|
+
<Language>FR</Language>
|
|
579
|
+
<FullName>LYNPARZA caps 50 mg 448 pce</FullName>
|
|
580
|
+
</Name>
|
|
581
|
+
</PackagedProduct>
|
|
582
|
+
</Article>
|
|
583
|
+
<Article>
|
|
584
|
+
<MedicinalProduct>
|
|
585
|
+
<Identifier>CH-7601001374539-31644</Identifier>
|
|
586
|
+
<Domain>Human</Domain>
|
|
587
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
588
|
+
<RegulatedAuthorisationIdentifier>3164401</RegulatedAuthorisationIdentifier>
|
|
589
|
+
<ProductClassification>
|
|
590
|
+
<ProductClass>PHARMA</ProductClass>
|
|
591
|
+
<Atc>B03AA07</Atc>
|
|
592
|
+
</ProductClassification>
|
|
593
|
+
</MedicinalProduct>
|
|
594
|
+
<PackagedProduct>
|
|
595
|
+
<Identifier>CH-7601001374539-31644-011</Identifier>
|
|
596
|
+
<RegulatedAuthorisationIdentifier>31644011</RegulatedAuthorisationIdentifier>
|
|
597
|
+
<DataCarrierIdentifier>7680316440115</DataCarrierIdentifier>
|
|
598
|
+
<Holder>
|
|
599
|
+
<Identifier>7601001374539</Identifier>
|
|
600
|
+
<Name>Farmaceutica Teofarma Suisse SA</Name>
|
|
601
|
+
</Holder>
|
|
602
|
+
<Name>
|
|
603
|
+
<Language>DE</Language>
|
|
604
|
+
<FullName>FERRO-GRADUMET Depottabl 30 Stk</FullName>
|
|
605
|
+
</Name>
|
|
606
|
+
<Name>
|
|
607
|
+
<Language>FR</Language>
|
|
608
|
+
<FullName>FERRO-GRADUMET cpr dépôt 30 pce</FullName>
|
|
609
|
+
</Name>
|
|
610
|
+
</PackagedProduct>
|
|
611
|
+
</Article>
|
|
612
|
+
<Article>
|
|
613
|
+
<MedicinalProduct>
|
|
614
|
+
<Identifier>CH-7601001000674-58158</Identifier>
|
|
615
|
+
<Domain>Human</Domain>
|
|
616
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
617
|
+
<RegulatedAuthorisationIdentifier>5815801</RegulatedAuthorisationIdentifier>
|
|
618
|
+
<ProductClassification>
|
|
619
|
+
<ProductClass>PHARMA</ProductClass>
|
|
620
|
+
<Atc>J07BD54</Atc>
|
|
621
|
+
</ProductClassification>
|
|
622
|
+
</MedicinalProduct>
|
|
623
|
+
<PackagedProduct>
|
|
624
|
+
<Identifier>CH-7601001000674-58158-001</Identifier>
|
|
625
|
+
<RegulatedAuthorisationIdentifier>58158001</RegulatedAuthorisationIdentifier>
|
|
626
|
+
<DataCarrierIdentifier>7680581580011</DataCarrierIdentifier>
|
|
627
|
+
<Holder>
|
|
628
|
+
<Identifier>7601001000674</Identifier>
|
|
629
|
+
<Name>GlaxoSmithKline AG</Name>
|
|
630
|
+
</Holder>
|
|
631
|
+
<Name>
|
|
632
|
+
<Language>DE</Language>
|
|
633
|
+
<FullName>PRIORIX TETRA Trockensub c Solv Fertspr</FullName>
|
|
634
|
+
</Name>
|
|
635
|
+
<Name>
|
|
636
|
+
<Language>FR</Language>
|
|
637
|
+
<FullName>PRIORIX TETRA subst sèche c solv ser pré</FullName>
|
|
638
|
+
</Name>
|
|
639
|
+
</PackagedProduct>
|
|
640
|
+
</Article>
|
|
641
|
+
<Article>
|
|
642
|
+
<MedicinalProduct>
|
|
643
|
+
<Identifier>CH-7601001308855-44447</Identifier>
|
|
644
|
+
<Domain>Human</Domain>
|
|
645
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
646
|
+
<RegulatedAuthorisationIdentifier>4444701</RegulatedAuthorisationIdentifier>
|
|
647
|
+
<ProductClassification>
|
|
648
|
+
<ProductClass>PHARMA</ProductClass>
|
|
649
|
+
<Atc>C07AB02</Atc>
|
|
650
|
+
</ProductClassification>
|
|
651
|
+
</MedicinalProduct>
|
|
652
|
+
<PackagedProduct>
|
|
653
|
+
<Identifier>CH-7601001308855-44447-010</Identifier>
|
|
654
|
+
<RegulatedAuthorisationIdentifier>44447010</RegulatedAuthorisationIdentifier>
|
|
655
|
+
<DataCarrierIdentifier>7680444470107</DataCarrierIdentifier>
|
|
656
|
+
<Holder>
|
|
657
|
+
<Identifier>7601001308855</Identifier>
|
|
658
|
+
<Name>Daiichi Sankyo (Schweiz) AG</Name>
|
|
659
|
+
</Holder>
|
|
660
|
+
<Name>
|
|
661
|
+
<Language>DE</Language>
|
|
662
|
+
<FullName>LOPRESOR Retard Divitabs 200 mg 14 Stk</FullName>
|
|
663
|
+
</Name>
|
|
664
|
+
<Name>
|
|
665
|
+
<Language>FR</Language>
|
|
666
|
+
<FullName>LOPRESOR Retard Divitabs 200 mg 14 pce</FullName>
|
|
667
|
+
</Name>
|
|
668
|
+
</PackagedProduct>
|
|
669
|
+
</Article>
|
|
670
|
+
<Article>
|
|
671
|
+
<MedicinalProduct>
|
|
672
|
+
<Identifier>CH-7601001308855-44447</Identifier>
|
|
673
|
+
<Domain>Human</Domain>
|
|
674
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
675
|
+
<RegulatedAuthorisationIdentifier>4444701</RegulatedAuthorisationIdentifier>
|
|
676
|
+
<ProductClassification>
|
|
677
|
+
<ProductClass>PHARMA</ProductClass>
|
|
678
|
+
<Atc>C07AB02</Atc>
|
|
679
|
+
</ProductClassification>
|
|
680
|
+
</MedicinalProduct>
|
|
681
|
+
<PackagedProduct>
|
|
682
|
+
<Identifier>CH-7601001308855-44447-029</Identifier>
|
|
683
|
+
<RegulatedAuthorisationIdentifier>44447029</RegulatedAuthorisationIdentifier>
|
|
684
|
+
<DataCarrierIdentifier>7680444470299</DataCarrierIdentifier>
|
|
685
|
+
<Holder>
|
|
686
|
+
<Identifier>7601001308855</Identifier>
|
|
687
|
+
<Name>Daiichi Sankyo (Schweiz) AG</Name>
|
|
688
|
+
</Holder>
|
|
689
|
+
<Name>
|
|
690
|
+
<Language>DE</Language>
|
|
691
|
+
<FullName>LOPRESOR Retard Divitabs 200 mg 56 Stk</FullName>
|
|
692
|
+
</Name>
|
|
693
|
+
<Name>
|
|
694
|
+
<Language>FR</Language>
|
|
695
|
+
<FullName>LOPRESOR Retard Divitabs 200 mg 56 pce</FullName>
|
|
696
|
+
</Name>
|
|
697
|
+
</PackagedProduct>
|
|
698
|
+
</Article>
|
|
699
|
+
<Article>
|
|
700
|
+
<MedicinalProduct>
|
|
701
|
+
<Identifier>CH-7601001000162-15219</Identifier>
|
|
702
|
+
<Domain>Human</Domain>
|
|
703
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
704
|
+
<RegulatedAuthorisationIdentifier>1521901</RegulatedAuthorisationIdentifier>
|
|
705
|
+
<ProductClassification>
|
|
706
|
+
<ProductClass>PHARMA</ProductClass>
|
|
707
|
+
<Atc>A01AA01</Atc>
|
|
708
|
+
</ProductClassification>
|
|
709
|
+
</MedicinalProduct>
|
|
710
|
+
<PackagedProduct>
|
|
711
|
+
<Identifier>CH-7601001000162-15219-068</Identifier>
|
|
712
|
+
<RegulatedAuthorisationIdentifier>15219068</RegulatedAuthorisationIdentifier>
|
|
713
|
+
<DataCarrierIdentifier>7680152190687</DataCarrierIdentifier>
|
|
714
|
+
<Holder>
|
|
715
|
+
<Identifier>7601001000162</Identifier>
|
|
716
|
+
<Name>MEDA Pharma GmbH</Name>
|
|
717
|
+
</Holder>
|
|
718
|
+
<Name>
|
|
719
|
+
<Language>DE</Language>
|
|
720
|
+
<FullName>ZYMAFLUOR Tabl 0.25 mg Ds 400 Stk</FullName>
|
|
721
|
+
</Name>
|
|
722
|
+
<Name>
|
|
723
|
+
<Language>FR</Language>
|
|
724
|
+
<FullName>ZYMAFLUOR cpr 0.25 mg bte 400 pce</FullName>
|
|
725
|
+
</Name>
|
|
726
|
+
</PackagedProduct>
|
|
727
|
+
</Article>
|
|
728
|
+
<Article>
|
|
729
|
+
<MedicinalProduct>
|
|
730
|
+
<Identifier>CH-7601001002173-43454</Identifier>
|
|
731
|
+
<Domain>Human</Domain>
|
|
732
|
+
<LegalStatusOfSupply>B</LegalStatusOfSupply>
|
|
733
|
+
<RegulatedAuthorisationIdentifier>4345401</RegulatedAuthorisationIdentifier>
|
|
734
|
+
<ProductClassification>
|
|
735
|
+
<ProductClass>PHARMA</ProductClass>
|
|
736
|
+
<Atc>D03AX99</Atc>
|
|
737
|
+
</ProductClassification>
|
|
738
|
+
</MedicinalProduct>
|
|
739
|
+
<PackagedProduct>
|
|
740
|
+
<Identifier>CH-7601001002173-43454-099</Identifier>
|
|
741
|
+
<RegulatedAuthorisationIdentifier>43454099</RegulatedAuthorisationIdentifier>
|
|
742
|
+
<DataCarrierIdentifier>7680434540995</DataCarrierIdentifier>
|
|
743
|
+
<Holder>
|
|
744
|
+
<Identifier>7601001002173</Identifier>
|
|
745
|
+
<Name>Iromedica AG</Name>
|
|
746
|
+
</Holder>
|
|
747
|
+
<Name>
|
|
748
|
+
<Language>DE</Language>
|
|
749
|
+
<FullName>KAMILLIN Medipharm Bad liq 10 Btl 40 ml</FullName>
|
|
750
|
+
</Name>
|
|
751
|
+
<Name>
|
|
752
|
+
<Language>FR</Language>
|
|
753
|
+
<FullName>KAMILLIN Medipharm bain liq 10 sach 40 ml</FullName>
|
|
754
|
+
</Name>
|
|
755
|
+
</PackagedProduct>
|
|
756
|
+
</Article>
|
|
757
|
+
<Article>
|
|
758
|
+
<MedicinalProduct>
|
|
759
|
+
<Identifier>7611600441020</Identifier>
|
|
760
|
+
<ProductClassification>
|
|
761
|
+
<ProductClass>NONPHARMA</ProductClass>
|
|
762
|
+
</ProductClassification>
|
|
763
|
+
</MedicinalProduct>
|
|
764
|
+
<PackagedProduct>
|
|
765
|
+
<Identifier>7611600441020</Identifier>
|
|
766
|
+
<DataCarrierIdentifier>7611600441020</DataCarrierIdentifier>
|
|
767
|
+
<Holder>
|
|
768
|
+
<Identifier>7601001000896</Identifier>
|
|
769
|
+
<Name>IVF HARTMANN AG</Name>
|
|
770
|
+
</Holder>
|
|
771
|
+
<Name>
|
|
772
|
+
<Language>DE</Language>
|
|
773
|
+
<FullName>TUBEGAZE Verband weiss Nr 12 20m Finger gross</FullName>
|
|
774
|
+
</Name>
|
|
775
|
+
<Name>
|
|
776
|
+
<Language>FR</Language>
|
|
777
|
+
<FullName>TUBEGAZE pans tubul blanc Nr 12 20m doigts grands</FullName>
|
|
778
|
+
</Name>
|
|
779
|
+
</PackagedProduct>
|
|
780
|
+
</Article>
|
|
781
|
+
<Article>
|
|
782
|
+
<MedicinalProduct>
|
|
783
|
+
<Identifier>00040565124308</Identifier>
|
|
784
|
+
<ProductClassification>
|
|
785
|
+
<ProductClass>NONPHARMA</ProductClass>
|
|
786
|
+
</ProductClassification>
|
|
787
|
+
</MedicinalProduct>
|
|
788
|
+
<PackagedProduct>
|
|
789
|
+
<Identifier>00040565124308</Identifier>
|
|
790
|
+
<DataCarrierIdentifier>00040565124308</DataCarrierIdentifier>
|
|
791
|
+
<Holder>
|
|
792
|
+
<Identifier>7601001251861</Identifier>
|
|
793
|
+
<Name>Smith & Nephew Schweiz AG</Name>
|
|
794
|
+
</Holder>
|
|
795
|
+
<Name>
|
|
796
|
+
<Language>DE</Language>
|
|
797
|
+
<FullName>ACTICOAT Flex 7 Wundverband 10x12.5cm 5 Stk</FullName>
|
|
798
|
+
</Name>
|
|
799
|
+
<Name>
|
|
800
|
+
<Language>FR</Language>
|
|
801
|
+
<FullName>ACTICOAT Flex 7 pansement vulné 10x12.5cm 5 pce</FullName>
|
|
802
|
+
</Name>
|
|
803
|
+
</PackagedProduct>
|
|
804
|
+
</Article>
|
|
805
|
+
<Article>
|
|
806
|
+
<MedicinalProduct>
|
|
807
|
+
<Identifier>00040565124346</Identifier>
|
|
808
|
+
<ProductClassification>
|
|
809
|
+
<ProductClass>NONPHARMA</ProductClass>
|
|
810
|
+
</ProductClassification>
|
|
811
|
+
</MedicinalProduct>
|
|
812
|
+
<PackagedProduct>
|
|
813
|
+
<Identifier>00040565124346</Identifier>
|
|
814
|
+
<DataCarrierIdentifier>00040565124346</DataCarrierIdentifier>
|
|
815
|
+
<Holder>
|
|
816
|
+
<Identifier>7601001251861</Identifier>
|
|
817
|
+
<Name>Smith & Nephew Schweiz AG</Name>
|
|
818
|
+
</Holder>
|
|
819
|
+
<Name>
|
|
820
|
+
<Language>DE</Language>
|
|
821
|
+
<FullName>ACTICOAT Flex 7 Wundverband 5x5cm 5 Stk</FullName>
|
|
822
|
+
</Name>
|
|
823
|
+
<Name>
|
|
824
|
+
<Language>FR</Language>
|
|
825
|
+
<FullName>ACTICOAT Flex 7 pansement vulné 5x5cm 5 pce</FullName>
|
|
826
|
+
</Name>
|
|
827
|
+
</PackagedProduct>
|
|
828
|
+
</Article>
|
|
829
|
+
<Article>
|
|
830
|
+
<MedicinalProduct>
|
|
831
|
+
<Identifier>68711428066649</Identifier>
|
|
832
|
+
<ProductClassification>
|
|
833
|
+
<ProductClass>NONPHARMA</ProductClass>
|
|
834
|
+
</ProductClassification>
|
|
835
|
+
</MedicinalProduct>
|
|
836
|
+
<PackagedProduct>
|
|
837
|
+
<Identifier>68711428066649</Identifier>
|
|
838
|
+
<DataCarrierIdentifier>68711428066649</DataCarrierIdentifier>
|
|
839
|
+
<Holder>
|
|
840
|
+
<Identifier>7610182000007</Identifier>
|
|
841
|
+
<Name>3M (Schweiz) GmbH (Professional Health Care)</Name>
|
|
842
|
+
</Holder>
|
|
843
|
+
<Name>
|
|
844
|
+
<Language>DE</Language>
|
|
845
|
+
<FullName>3M MEDIPORE+PAD Absorbtionsverb 10x15cm 8 x 25 Stk</FullName>
|
|
846
|
+
</Name>
|
|
847
|
+
<Name>
|
|
848
|
+
<Language>FR</Language>
|
|
849
|
+
<FullName>3M MEDIPORE+PAD compr absorb 10x15cm 8 x 25 pce</FullName>
|
|
850
|
+
</Name>
|
|
851
|
+
</PackagedProduct>
|
|
852
|
+
</Article>
|
|
853
|
+
</Articles>
|